Exergaming Revolution in Dementia

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
AgeNot listed
SponsorEastern Switzerland University of Applied Sciences

About this trial

This pilot randomized controlled trial evaluates the effect of a 12 weeks exergaming training in people with major neurocognitive disorders (MNCD) living in long-term care facilities.

Eligibility criteria

Qualifiers

Neurocognitive disorder based on Alzheimer's Disease, Parkinson's disease, Lewy body dementia or Mixed dementia according to the criteria of the American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM 5)

Mini-Mental-Status-Examination (MMSE) Score of ≥5 and ≤26 out of e maximum of 30

Disqualifiers

MMSE <5

Unstable cardiovascular condition or other medical condition that does not allow for safe participation according to the recommendations of the American College of Sports Medicine

Planned transfer to another facility within the next 3 months

Acute behavioural problems

Trial design

Treatments tested in this trial

  • Exergaming on Dividat Senso
  • Usual Care

Treatment groups

48 Participants
are divided into 2 treatment groups